The following clinical symptom characteristics were considered diagnostic for temporal lobe epilepsy: ascending epigastric aura or fear followed by complex partial seizures (CPS) characterized by staring and oropharyngeal automatisms (smacking lips, masticating) which may be accompanied by ipsilateral superior limb automatisms or contralateral superior limb dystonia, possibly progressing late to generalized tonic-clonic activity. The cause of epilepsy was not yet clear, which might be associated with birth injury, craniocerebral injury and febrile convulsion ( Table 1) .
Two patients underwent stereotactic depth electrodes implantation for intracranial invasive monitoring to localize ictal onset zone before DBS electrodes implantation because of insufficient proof on scalp video-EEG recordings. Multiple contact intracerebral electrodes (diameter, 0.8 mm; 5-18 contacts, 1.5 mm in length and 2 mm apart [Dixi Medical, Besançon, France]) were implanted. A high resolution CT scan was performed after implantation of the SEEG electrodes to evaluate lesions and coregistered with the preoperative 3D T1-weighted MRI to allow precise localization of the electrode contacts. It took ten days from removal of the depth recording electrodes to implantation of DBS electrodes.
These entry standards included: (1) seizure frequency of at least one complex partial seizure per month, (2) epileptic discharges in temporal lobes due to scalp video-EEG recording, (3) ictal onset zone located in unilateral temporal lobe owing to invasive video-EEG monitoring and (4) no lesion in MRI scan.
All candidates understood the operational risks and curative effects fully, signed their operation informed consents in this study conducted by the Ethics Committee of Hebei Medical University.
Implantation procedure of DBS electrodes and stimulation paradigm
A computerized tomography scan acquired under stereotaxic head frame (CRW, Radionics, USA) was fused with the 3D T1-weighted MRI. A plan was made based on stereotactic CT/ MRI fusion. The permanent quadripolar DBS electrodes (Medtronic 3487A) were inserted into the bilateral hippocampal heads perpendicular to the hippocampal longitudinal axis through frontal burr holes under general anesthesia. The third and fourth contacts were located in hippocampal head on each side as determined by the fused CT/MRI datasets, while the first and second contacts were located in parahippocampal gyrus (Fig. 1) . Intra-operative neuronavigation was used during electrode insertion. Each electrode has four cylindrical contacts. The electrodes were connected to the ipsilateral pulse generators (Medtronic Soletra 7426) implanted in subclavicular pockets through the subcutaneous wires (Fig. 2) .
Chronic continuous high frequency stimulation was employed during treatment. The pulse width was set to 450 ms and remained unchanged in the whole course of treatment. The quadripolar configuration of DBS was employed in which the first contact was set as cathode and the fourth contact was set as the anode. The stimulating frequencies of 130, 150 and 170 Hz were suggested in patients 1, 2, and 3 respectively.
The voltage was increased gradually by 0.1 V every 2 months if the DBS failed to decrease seizures by 90%, to a highest at 3.5 V, or until the patients became seizure-free or adverse reactions appeared. 
AEDs
Therapeutic schemes were in accordance with pre-implantation to assess the curative effect of DBS expediently. Subtle change of drug dosages was permitted but taking any new antiepileptic drug was not allowed. The AED regimen was tapered according to best medical practice.
Neuropsychological evaluation
All the cases were tested by Wechster Adult Intelligence ScaleRevised China (WAIS-RC) and Wechsler memory scale-revised in China (WMS-RC) before and 1 year after DBS.
Follow-up and data analysis
All the subjects were followed up on out-patient review every 2 weeks during the first three months after hospital discharge, every three months afterward, or more frequently when necessary. Seizure frequency, seizure intensity, adverse events and pharmacotherapy were carefully recorded on a seizure diary. Simulation parameters were adjusted or unilateral hippocampal stimulation was switched to bilateral hippocampal stimulation due to longterm follow-up relevant assessments.
Follow-up time ranged from 26 to 43 months (mean = 34.7 months). The mean number of seizures per month averaged over the last six months before implantation except the presurgical evaluation time was established as control and the mean number of monthly seizures averaged over the maximal follow-up time after implantation was established as intervention.
Because there were too few samples in this research for a valid statistical interpretation, we have to describe the results.
Results
Bilateral temporal lobe spikes of interictal non-invasive EEG were showed in two patients (patients 2 and 3), and unilateral temporal lobe spikes in patient 1. Seizures originating from the left temporal lobe of ictal non-invasive EEG recordings were showed in two patients (patients 1 and 2) and from both temporal lobe in patient 3.
The ictal onset which generated from unilateral mesial temporal lobe and conducted to the contralateral medial temporal structures within a few seconds was detected in patient 3 on the invasive video-EEG monitoring.
In patient 1, a focal ictal onset in left mesial temporal lobe and ipsilateral interictal spikes were discovered from non-invasive EEG recordings, which was verified by the local cerebral glucose metabolism decrease in left mesial temporal lobe on PET without invasive EEG monitoring (Fig. 3) .
In patient 2, the left mesial temporal lobe ictal onset and bilateral mesial temporal lobe interictal spikes were showed on scalp video-EEG, which was confirmed by the focal left-sided hippocampal ictal onset zone on intracranial EEG (Fig. 4) .
In patient 3, ictal nonsynchronous epileptiform discharges in both temporal lobes were found on scalp video-EEG recordings, whereas a right-sided medial temporal lobe regional ictal onset zone spreading to the contralateral temporal lobe was detected on medial temporal lobe and parahippocampal electrode contacts of invasive EEG monitoring (Fig. 5) .
Postoperative seizure frequencies were compared with preoperative ones. High-frequency chronic Hip-DBS was able to reduce seizure frequency in this series. All the patients suffered from refractory complex partial seizures with (patient 3) or without (patients 1 and 2) occasional secondary generalized tonic-clonic Fig. 3 . Ictal onset of patient 1 on scalp video-EEG. A continuity of low or middle amplitude slow wave followed by middle or high spike wave rhythms was detected by left temporal leads (M1, F7, T3) during ictal scalp video-EEG.
seizures. Overall seizure frequency reduction ranged from 91 to 95% (mean = 93%) in patients. Patient 1, 2 and 3 experienced respectively a 95%, 92% and 91% reduction in seizure frequency after hippocampal DBS.
Two patients (patients 1 and 2) were activated unilaterally and one patient was activated (patient 3) bilaterally. The activated side was determined by the ictal onset zone on initial EEG recordings or predominant discharges. The second side was activated unless the first activated side failed to decrease seizure by 90%. Although the seizure-frequency reduction of patient 3 after activated bilaterally was relatively inadequate, generalized tonic-clonic seizures disappeared completely in patient 3. The output voltage ranged from 1.0 V to 2.5 V ( Table 2) .
Patient 1 responded well to the initial stimulation settings (output, 1.0 V; frequency, 130 Hz; pulse width, 450 microseconds) and achieved a firm 95% seizure frequency reduction. Patient 2 gained a stable 92% seizure frequency reduction using these stimulating parameters (output, 1.6 V; frequency, 150 Hz; pulse width, 450 microseconds).
In patient 3, right-sided hippocampal DBS (output, 2.5 V; frequency, 170 Hz; pulse width, 450 microseconds) failed to decrease seizure frequency by more than 90% after 30 months of follow-up, and then left-sided hippocampal DBS (output, 1.5 V; frequency, 170 Hz; pulse width, 450 microseconds) was added, a steady 91% seizure frequency reduction was obtained after switching to bilateral DBS.
There was no postoperative neuropsychological deterioration presented and all the data were within the normal range (Table 3) .
There was no lesion in T1 and T2 weighted images of preoperative MRI (Fig. 6 ).
Discussion
In patients with nonlesional refractory temporal lobe epilepsy, no underlying pathological abnormalities such as hippocampal sclerosis, focal cortical dysplasias, vascular or traumatic lesion can be demonstrated on MRI. Seizure outcome after resective surgery in these patients is less advantageous than those patients with structural abnormality. In addition, the excision of MRI-negative temporal lobe structure is associated with a higher risk for postoperative neuropsychological deficit [5, 9, 10] . The verbal memory decline and visual-spatial learning impairment was observed after resection of non-atrophic hippocampus in left and right temporal lobe epilepsy respectively [11] [12] [13] . Less than 15% of patients with long-term seizure freedom through temporal lobectomy may recur [14] . Therefore, temporal lobe resection may not be suitable for all people with refractory epilepsy, especially for patients with normal MRI scan. For these patients, hippocampal DBS as an alternative procedure is available, partly with definite curative effects.
Hippocampal DBS has been shown to be successful in the treatment of nonlesional refractory temporal lobe epilepsy, despite a relatively small number of patients in this study. The group of patients with normal MRI had comparable results to the same kind of cases reported by Velasco et al. [15] . These authors observed consecutively the seizure outcome in hippocampal DBS of nine patients (Five had normal MRI scan with a seizure frequency reduction of >95%, while the rest four had hippocampal sclerosis with a seizure frequency reduction of 50-70%) with refractory temporal lobe epilepsy ranging from 18 months to 7 years and came to a conclusion that patients with normal MRI scan would respond better to hippocampal DBS, this was noted in this series. Vonck et al. also confirmed that hippocampal DBS in patients with normal MRI scan brought about a significant decrease of seizures and interictal epileptiform discharges [16] .
There are several possible reasons for the less effective DBS in cases with hippocampal sclerosis [15, 17, 18] . First, the incomplete neuronal network attributing to serious lack of neurons in sclerotic mesial temporal tissue was insensitive to hippocampal DBS. Second, the impedance of sclerotic hippocampus was high and resistant to stimulative current, although the patients received approximately the same voltage with or without hippocampal sclerosis. Third, the sclerotic hippocampus was atrophic which might cause the DBS electrode to departure from stimulating target. Finally, epileptic patients with normal MRI were good responders to hippocampal DBS.
The stimulating parameters should be taken into account when assessing the efficacy of hippocampal DBS because seizure outcomes were influenced directly by stimulating parameters. Moreover, stimulating parameters should be tailored individually for the most effective epileptic DBS parameters have not yet been reached a consensus. The seizure reduction in hippocampal stimulation with highfrequency (130-190 Hz) was shown on this research which was in agreement with several reports [19] [20] [21] . Bö ex and his colleagues carried out a comparative study of high (130 Hz) and low (5 Hz) frequency electrical stimulation in nonlesional temporal lobe epilepsy and drew a conclusion that high-frequency, but not lowfrequency stimulation was associated with a seizure reduction [22] , as we noted in this series. The EEG desynchronization induced by high-frequency stimulation might produce an antiepileptic action.
Seizure outcome was likely to be ameliorated through increasing the output voltage gradually within the patient's tolerance. Stimulating voltage was set initially at 1.0 V and increased at 0.1 V to a maximum of 2.5 V. Patient 1 and 2 accepted the electric stimulation at 1.0 V and 1.6 V respectively in case that the seizure frequency reduction of 90%. Patient 3 experienced bilateral activation with left voltage of 1.5 V and right of 2.5 V.
The voltage increment of 0.1 V was safe and effective without adverse reactions in this study, as applied in some reports [16] . Seizure frequency might increase abnormally in the event that voltage increment during hippocampal DBS exceed 0.2 V, which was confirmed by Cukiert et al.: seizure frequency had deteriorated in three patients for the augmenter of voltage was set at 0.5 V [18] . Voltage increment was suggested to be set at 0.1 V based on the results of this study.
For the purpose of abolishing epilepsy or reducing seizure frequency, a high intensity was applied in hippocampal deep brain stimulation. Boë x et al. indicated that low voltage (<1.0 V) accompanying with bipolar configuration lead to increase of seizure frequency [23] , therefore, the initial voltage was set to 1.0 V. Tellez-Zenteno and his colleagues reported that the seizure frequency increased surprisingly in one patient of his study who underwent hippocampal stimulation in a quadripolar configuration with a high voltage of 4.5 V, a pulse of 90 ms and at a frequency of 190 Hz [24] . These findings suggested that high or low voltage might produce excitatory effects thus voltage should be within a suitable range in order to obtain a reduction in seizure frequency. The voltage between 1.0 V and 2.5 V is safe and effective for the patients with nonlesional refractory temporal lobe epilepsy.
The mechanism of hippocampal stimulation in treatment of patients with mesial temporal lobe epilepsy is in the course of exploration. Velasco et al. have suggested that the perforant pathway activated by DBS might lead to a polysynaptic inhibition of epileptogenic neurons in hippocampal CA1-CA4 regions in charge of the initiation and/or propagation of temporal lobe epilepsy [25] . A more likely hypothesis that hippocampal structure as the hub in temporal lobe epileptogenic network is potentially involved in generation and/or propagation of epileptiform activity and stimulative current of DBS could inhibit ictal focus and propagation paths has been taken [26] [27] [28] [29] . We endorsed this thesis that hippocampal DBS exert an inhibitory effect not only on ictal focus but also the epileptogenic network through local and remote modulation of network excitability.
Recently, several studies have highlighted that the hyperexcitable subiculum might take part in the generation and propagation of temporal lobe epilepsy [30] [31] [32] [33] . According to these reports, a satisfactory result was achieved in our study by means of highfrequency stimulating hippocampus and subiculum simultaneously to decrease the excitability of subiculum.
Because of too few cases in this research and lack of randomized control experiment, the optimal parameters for DBS remain unclear.
In conclusion, hippocampal DBS may represent both a less traumatic and more efficient therapeutic regimen for patients with nonlesional refractory temporal lobe epilepsy via the individualized therapeutic regimen and optimum combination of various parameters.
